Skip to main content

Chronic kidney disease

Browse the latest news, expert commentary, and educational content on chronic kidney disease.


06-29-2021 | ADA 2021 | Conference coverage | News

AMPLITUDE-O: Efpeglenatide offers cardiorenal protection in type 2 diabetes

Efpeglenatide provides significant cardiovascular and renal protection in people with type 2 diabetes at high risk for cardiorenal events, show the findings of the AMPLITUDE-O trial.

06-10-2021 | Adverse effects | News

Steep eGFR drop on SGLT2 inhibitor initiation may pose cardiorenal risk

The small proportion of people who experience an eGFR fall of more than 30% on starting an SGLT2 inhibitor may be at increased risk for adverse outcomes, research suggests.

05-04-2021 | Medications | News

Objective assessment of medication taking advised to reduce type 2 diabetes complications

Suboptimal medication-taking identified through urine testing is associated with a higher prevalence of microvascular and macrovascular complications in people with type 2 diabetes than found with consistent usage, report researchers.

More on chronic kidney disease

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits